Progress in Myelodysplastic Syndromes: Clinicopathologic Correlations and Immune Checkpoints
|
Jul 2017
|
Clin Lymphoma Myeloma Leuk
|
myelodysplastic syndromes (MDS)
|
Prognostic Factors Associated With Disease Progression and Overall Survival in Patients With Myelodysplastic Syndromes Treated With Decitabine.
|
Dec 2012
|
Clin Lymphoma Myeloma Leuk
|
myelodysplastic syndromes (MDS)
|
Lenalidomide Treatment for Lower Risk Nondeletion 5q Myelodysplastic Syndromes Patients Yields Higher Response Rates When Used Before Azacitidine
|
Nov 2015
|
Clin Lymphoma Myeloma Leuk
|
myelodysplastic syndromes (MDS)
|
Clinical Benefit-Risk Profile of Lenalidomide in Patients With Lower-risk Myelodysplastic Syndromes Without del(5q): Results of a Phase III Trial.
|
Dec 2018
|
Clin Lymphoma Myeloma Leuk
|
myelodysplastic syndromes (MDS)
|
A Phase II Study to Determine the Safety and Efficacy of the Oral Inhibitor of Indoleamine 2,3-Dioxygenase (IDO) Enzyme INCB024360 in Patients with Myelodysplastic Syndromes
|
Mar 2019
|
Clin Lymphoma Myeloma Leuk
|
myelodysplastic syndromes (MDS)
|
Immunomodulatory Drugs: New Options for the Treatment of Myelodysplastic Syndromes
|
Nov 2012
|
Clin Lymphoma Myeloma Leuk
|
myelodysplastic syndromes (MDS)
|
Non-t(6;9) and Non-Inv(3) Balanced Chromosomal Rearrangements Are Associated With Poor Survival Outcomes in Myelodysplastic Syndromes
|
Apr 2015
|
Clin Lymphoma Myeloma Leuk
|
myelodysplastic syndromes (MDS)
|
Myelodysplastic Syndromes and Acute Myeloid Leukemia in the Elderly
|
Feb 2016
|
Clin Geriatr Med
|
myelodysplastic syndromes (MDS)
|
The complex pathophysiology of acquired aplastic anemia
|
Feb 2015
|
Clin Exp Immunol
|
aplastic anemia
|
Performance characteristics of consensus approaches for small and minor paroxysmal nocturnal hemoglobinuria clone determination by flow cytometry.
|
Jun 2013
|
Clin Chem Lab Med
|
myelodysplastic syndromes (MDS)
|